Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 3 EP applications Mark Didmon has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 24, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11760819

COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 - SPECIFIC ANTIBODIES

IPC classification:
A61K 39/395, A61P 35/02, C07K 16/28
Applicant:
University of Southampton
Agent:
Mark Didmon, Potter Clarkson LLP
Status:
The patent has been granted
EP11755433

SELF-ADJUSTING BRA STRAP

IPC classification:
A41C 3/00, A41F 15/00
Agent:
Mark Didmon, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11731575

METHODS FOR IN SITU DETECTION OF NUCLEOTIDE SEQUENCES

IPC classification:
C12Q 1/68
Agent:
Mark Didmon, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature